1158985-17-1

Basic information

• Product Name: (S)-3-aminoheptan-1-ol
• Synonyms: (S)-3-aminoheptan-1-ol;(S)-3-aoheptan-1-ol
• CAS NO: 1158985-17-1
• Molecular Formula: C₇H₁₇NO
• Molecular Weight: 131
• Mol File: 1158985-17-1.mol

Chemical Properties

• Boiling Point: 226.2±13.0 °C(Predicted)
• Appearance: /
• Density: 0.900±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 15.00±0.10(Predicted)
• CAS DataBase Reference: (S)-3-aminoheptan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-aminoheptan-1-ol(1158985-17-1)
• EPA Substance Registry System: (S)-3-aminoheptan-1-ol(1158985-17-1)

Safety Data

• Hazardous Substances Data: 1158985-17-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
(S)-3-aminoheptan-1-ol is used as a starting material for the preparation of various pharmaceutical compounds. Its unique structure and chirality make it a valuable component in the development of new drugs with specific therapeutic properties.
Used as a Chiral Building Block:
In the field of organic chemistry, (S)-3-aminoheptan-1-ol is employed as a chiral building block for the synthesis of complex organic molecules. Its presence can influence the stereochemistry of the final product, which is crucial for the biological activity and selectivity of the synthesized compounds.
Used in Asymmetric Catalysis:
(S)-3-aminoheptan-1-ol is used as a precursor in the production of chiral ligands for asymmetric catalysis. These ligands are essential for enantioselective reactions, where the synthesis of one enantiomer is favored over the other, leading to more efficient and selective chemical processes.
Used in Medicinal Research:
Due to its biological activity, (S)-3-aminoheptan-1-ol is being studied for its potential therapeutic uses in medicine. Its unique properties and interactions with biological systems may lead to the discovery of new treatments for various diseases and conditions.

Upstream product

• 129488-82-0 (E)-tert-butyl hept-2-enoate 
• 1158803-94-1 tert-butyl (S)-3-(benzyl((S)-1-phenylethyl)amino)heptanoate 
• 110-62-3 pentanal 
• 1158803-96-3 (S)-3-(benzyl((S)-1-phenylethyl)amino)heptan-1-ol 

Downstream Products

• 1402805-46-2 C₂₀H₂₈N₄O₃ 

Relevant articles and documents

PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS

The present disclosure relates to a class of pyrimidine derivatives having immunomodulating properties that act via TLR7 which are useful in the treatment of lung cancer and other respiratory conditions.

TLR7 PEPTIDE CONJUGATES

The present disclosure relates to a class of pyrimidine derivative peptide conjugates having enhanced immunomodulating properties. More specifically the peptide conjugate contains a TLR7 agonist and enhances the biological effect of the peptide to which i

Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus

Toll-like receptor (TLR) 7 and 8 agonists can potentially be used in the treatment of viral infections and are particularly promising for chronic hepatitis B virus (HBV) infection. An internal screening effort identified a pyrimidine Toll-like receptor 7 and 8 dual agonist. This provided a novel alternative over the previously reported adenine and pteridone type of agonists. Structure-activity relationship, lead optimization, in silico docking, pharmacokinetics, and demonstration of ex vivo and in vivo cytokine production of the lead compound are presented.

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as HCV or HBV.

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

This invention relates to quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy of disorders in which the modulation of toll-like-receptors is involved.

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

This invention relates to pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections such as HCV or HBV.

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

This invention relates to quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy of disorders in which the modulation of toll - like - receptors is involved.

NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES

The invention concerns compounds of Formula (I): wherein L1, R1, R2, R3, R4 and X are as defined in the description. The present invention also relates to processes for the preparation of such compoun

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ASTHMA, COPD, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, ATOPIC DERMATITIS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, BACTERIAL INFECTIONS AND DERMATOSIS

The present invention provides compounds of formula (I) wherein R 1, R2, R3 and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.